Skip to main content
Recent Patents on CNS Drug Discovery publishes review articles on recent patents in the field of CNS drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on CNS drug discovery is also included in the journal. The journal is essential reading for all researchers involved in CNS drug design and discovery.

Publisher: Bentham Science Publishers

Volume 1, Number 3, 2006

Articles

In Search of Novel AMPA Potentiators
pp. 239-246(8)
Authors: Francotte, Pierre; de Tullio, Pascal; Fraikin, Pierre; Counerotte, Stephane; Goffin, Eric; Pirotte, Bernard

Favourites:
ADD

AMPA Receptor Antagonists: Potential Therapeutic Applications
pp. 247-259(13)
Authors: Mattes, Henri; Lingenhoehl, Kurt; Kalkman, Hans; Auberson, Yves; Renaud, Johanne; Schmutz, Markus; Orain, David

Favourites:
ADD

Halogenated Derivatives of Aromatic Amino Acids Exhibit Balanced Antiglutamatergic Actions: Potential Applications for the Treatment of Neurological and Neuropsychiatric Disorders
pp. 261-270(10)
Authors: Martynyuk, Anatoly E.; Seubert, Christoph N.; Yarotskyy, Viktor; Glushakov, Alexander V.; Gravenstein, Nikolaus; Sumners, Colin; Dennis, Donn M.

Favourites:
ADD

Selective Dopamine D3 Receptor Antagonists: A Review 2001-2005
pp. 271-288(18)
Authors: Micheli, Fabrizio; Heidbreder, Christian

Favourites:
ADD

Recent Developments in Anxiety Disorders
pp. 289-298(10)
Authors: Christmas, David M.; Hood, Sean D.

Favourites:
ADD

Therapeutic Potential of Adult Neural Stem Cells
pp. 299-303(5)
Author: Taupin, Philippe

Favourites:
ADD

The Hypothalamus and Obesity
pp. 305-314(10)
Authors: Harrold, Joanne A.; G. Halford, Jason C.

Favourites:
ADD

Neuropeptide Y as an Endogenous Antiepileptic, Neuroprotective and Pro-Neurogenic Peptide
pp. 315-324(10)
Authors: Xapelli, Sara; Agasse, Fabienne; Ferreira, Raquel; Silva, Ana P.; Malva, Joao O.

Favourites:
ADD

Patent Annotations
pp. 325-327(3)

Favourites:
ADD

Patent Selections
pp. 329-338(10)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content